Qbtech Launches Breakthrough Product In The U.S.: First Test Cleared By FDA To Provide Unbiased Evaluation Of ADHD Treatment

STOCKHOLM--(BUSINESS WIRE)--The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD. QbTest is a computer-based test providing clinicians with objective and unbiased decision-making support when diagnosing and treating ADHD in children, adolescents and adults. QbTest is the only test in the world cleared by the FDA for this usage.

Help employers find you! Check out all the jobs and post your resume.